• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

委员会报告:推进当前推荐的新生儿筛查疾病清单

Committee Report: advancing the current recommended panel of conditions for newborn screening.

作者信息

Green Nancy S, Rinaldo Piero, Brower Amy, Boyle Coleen, Dougherty Denise, Lloyd-Puryear Michele, Mann Marie Y, Howell Rodney R

机构信息

Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.

出版信息

Genet Med. 2007 Nov;9(11):792-6. doi: 10.1097/gim.0b013e318159a38e.

DOI:10.1097/gim.0b013e318159a38e
PMID:18007148
Abstract

The Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children is charged with advising the Secretary of the US Department of Health and Human Services in areas relevant to heritable conditions in children, especially newborn screening (NBS). This report describes the formulation by the Committee of a new process to nominate and review conditions to the recommended universal NBS panel. Nominations are currently being solicited. Committee review will adhere to the fundamental principles of being transparent, broadly accessible, evidence-based and consistent across the process for all of the proposed conditions across the process.

摘要

新生儿及儿童遗传性疾病咨询委员会负责就与儿童遗传性疾病相关的领域,特别是新生儿筛查(NBS),向美国卫生与公众服务部部长提供建议。本报告描述了委员会制定的一个新流程,用于提名和审查纳入推荐的通用新生儿筛查项目的疾病。目前正在征集提名。委员会的审查将遵循透明、广泛参与、基于证据以及在整个流程中对所有拟议疾病保持一致的基本原则。

相似文献

1
Committee Report: advancing the current recommended panel of conditions for newborn screening.委员会报告:推进当前推荐的新生儿筛查疾病清单
Genet Med. 2007 Nov;9(11):792-6. doi: 10.1097/gim.0b013e318159a38e.
2
From developing guidelines to implementing legislation: actions of the US Advisory Committee on Heritable Disorders in Newborns and Children toward advancing and improving newborn screening.从制定指南到实施立法:美国新生儿和儿童遗传性疾病咨询委员会在推进和改善新生儿筛查方面的行动。
Semin Perinatol. 2010 Apr;34(2):121-4. doi: 10.1053/j.semperi.2009.12.004.
3
Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.在出生证明上包括初始新生儿筛查采血设备序列号:卫生与公众服务部遗传性新生儿和儿童疾病咨询委员会的依据和建议。
Genet Med. 2013 Mar;15(3):229-33. doi: 10.1038/gim.2012.121. Epub 2012 Oct 4.
4
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.被提名列入推荐统一筛查小组的条件的决策过程:美国卫生与公众服务部部长遗传性新生儿和儿童疾病咨询委员会的声明。
Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1.
5
Impact of expanded newborn screening--United States, 2006.扩大新生儿筛查的影响——美国,2006年
MMWR Morb Mortal Wkly Rep. 2008 Sep 19;57(37):1012-5.
6
What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.新生儿筛查长期随访应能回答哪些问题?美国卫生与公众服务部遗传性新生儿及儿童疾病咨询委员会的声明。
Genet Med. 2011 Oct;13(10):861-5. doi: 10.1097/GIM.0b013e3182209f09.
7
Advisory committee on heritable disorders and genetic diseases in newborns and children.新生儿及儿童遗传性疾病咨询委员会
Ment Retard Dev Disabil Res Rev. 2006;12(4):313-5. doi: 10.1002/mrdd.20126.
8
Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children.新生儿筛查诊断后的长期随访:美国卫生与公众服务部新生儿及儿童遗传性疾病咨询委员会声明
Genet Med. 2008 Apr;10(4):259-61. doi: 10.1097/GIM.0b013e31816b64f9.
9
Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.遗传代谢病生化遗传检测和新生儿筛查的良好实验室规范。
MMWR Recomm Rep. 2012 Apr 6;61(RR-2):1-44.
10
Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.琥珀酰丙酮作为检测新生儿I型酪氨酸血症的主要标志物及其在新生儿筛查项目中的测定。
Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75. doi: 10.1016/j.ymgme.2014.07.010. Epub 2014 Jul 17.

引用本文的文献

1
Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One).基于人群的新生儿筛查:新生儿筛查扩展研究的结果(第一部分)
Front Genet. 2022 Jul 22;13:867337. doi: 10.3389/fgene.2022.867337. eCollection 2022.
2
Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis.系统评价在新生儿罕见病筛查中应用与国家政策建议的关联:系统评价和荟萃分析。
BMJ. 2018 May 9;361:k1612. doi: 10.1136/bmj.k1612.
3
A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).
一种用于低丙种球蛋白血症的新型靶向筛查工具:通过干血斑检测血清免疫球蛋白(IgG、IgM、IgA)水平(Ig-DBS检测法)
J Clin Immunol. 2015 Aug;35(6):573-82. doi: 10.1007/s10875-015-0184-y. Epub 2015 Aug 16.
4
Genomics and perinatal care.基因组学与围产期护理。
N Engl J Med. 2012 Jan 5;366(1):64-73. doi: 10.1056/NEJMra1105043.
5
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.共识声明:对于患有发育障碍或先天畸形的个体,染色体微阵列是一线临床诊断测试。
Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006.
6
Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.腺相关病毒基因治疗长期挽救致死性甲基丙二酸血症的小鼠模型。
Mol Ther. 2010 Jan;18(1):11-6. doi: 10.1038/mt.2009.247. Epub 2009 Oct 27.
7
Challenges of translating genetic tests into clinical and public health practice.将基因检测转化为临床和公共卫生实践面临的挑战。
Nat Rev Genet. 2009 Jul;10(7):489-95. doi: 10.1038/nrg2606.
8
Fragile X screening: attitudes of genetic health professionals.脆性X综合征筛查:遗传健康专业人员的态度
Am J Med Genet A. 2009 Feb 15;149A(4):626-32. doi: 10.1002/ajmg.a.32725.